The Estée Lauder Companies Inc. Increases Quarterly Dividend 25% to $.30 Per Share
Get Alerts EL Hot Sheet
Join SI Premium – FREE
NEW YORK--(BUSINESS WIRE)-- The Estée Lauder Companies Inc. (NYSE: EL) announced today an increase in the quarterly dividend on the Company’s Class A and Class B Common Stock to $.30 per share. The dividend amount represents a 25% increase over the previous quarterly rate of $.24 per share. The $.30 per share quarterly dividend will be payable on December 15, 2015 to stockholders of record at the close of business on November 30, 2015.
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers and marketers of quality skin care, makeup, fragrance and hair care products. The Company’s products are sold in over 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Prescriptives, Lab Series, Origins, Tommy Hilfiger, M•A•C, Kiton, La Mer, Bobbi Brown, Donna Karan New York, DKNY, Aveda, Jo Malone London, Bumble and bumble, Michael Kors, Darphin, GoodSkin Labs, Tom Ford, Ojon, Smashbox, Ermenegildo Zegna, AERIN, Osiao, Marni, Tory Burch, RODIN olio lusso, Le Labo, Editions de Parfums Frédéric Malle and GLAMGLOW.
An electronic version of this release can be found at the Company’s website, www.elcompanies.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151102005407/en/
The Estée Lauder Companies Inc.
Investor Relations:
Dennis
D’Andrea, 212-572-4384
or
Media Relations:
Alexandra
Trower, 212-572-4430
Source: The Estée Lauder Companies Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Reinstates Estee Lauder (EL) at Buy
- Cognivia Announces Collaboration to Advance Behavioral Intelligence Across Clinical Research and Clinical Care
- SRX Global Makes Strategic Investment in Clinical-Stage Biodefense Company, ARMR Sciences
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share